Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. A.A. (Adriaan) Voors

Publicaties

A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HF

Activation of Neutrophil Extracellular Trap Formation in Patients with Heart Failure and a Preserved Ejection Fraction

Acute Heart Failure: Transitioning From Symptom-Based Care to Remission

Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction

Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure

Characteristics, clinical outcomes and molecular mechanisms associated with severe diastolic dysfunction in aortic stenosis

Clinical and artificial intelligence assessed echocardiographic predictors of outcomes after acute myocardial infarction

Corrigendum to “Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacologic Substudy”(Journal of Cardiac Failure, (2025), 31, 10, (1578-1581), (S1071916425002386), 10.1016/j.cardfail.2025.04.015)

Decoding the Heart Failure Peptidome

Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF Trial

Pers/media

Where do GLP-1 receptor agonists fit in heart failure care?

Men Have High Levels Of Enzyme Key To COVID-19

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Novità nel trattamento dello scompenso cardiaco acuto

Health Industry News

PRNewswire Latest Health News

EMPULSE shows empagliflozin benefit in acute heart failure

Sustainable Development Goals

SDG 2 – Geen hongerSDG 3 – Goede gezondheid en welzijnSDG 9 – Industrie, innovatie en infrastructuur

Meer informatie over de Sustainable Development Goals.